mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for TJP1
Gene summary
Basic gene Info.Gene symbolTJP1
Gene nametight junction protein 1
SynonymsZO-1
CytomapUCSC genome browser: 15q13
Type of geneprotein-coding
RefGenesNM_001301025.1,
NM_001301026.1,NM_003257.4,NM_175610.3,
Descriptiontight junction protein ZO-1zona occludens 1zonula occludens 1 protein
Modification date20141207
dbXrefs MIM : 601009
HGNC : HGNC
Ensembl : ENSG00000104067
HPRD : 03002
Vega : OTTHUMG00000137397
ProteinUniProt: Q07157
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_TJP1
BioGPS: 7082
PathwayNCI Pathway Interaction Database: TJP1
KEGG: TJP1
REACTOME: TJP1
Pathway Commons: TJP1
ContextiHOP: TJP1
ligand binding site mutation search in PubMed: TJP1
UCL Cancer Institute: TJP1
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for TJP1

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
V484A483VCOAD1
L242S241ACOAD1
N239M240ICOAD1
K209E210ACOAD1
V450V450ICOAD1
D514D514HKIRC1
I249R251MLUAD1
L554,L558S556FSKCM1
L256G254CUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for TJP1
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
I249R251M-1.2574563
L242S241A-1.149576
D514D514H-0.9851372
V450V450I-0.92439598
K209E210A-0.69295144
N239M240I-0.47196353
L554S556F-0.24733621
L558S556F-0.24733621
L256G254C-0.22915134
V484A483V-0.18535439
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for TJP1 from PDB

Top
Differential gene expression and gene-gene network for TJP1
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of TJP1 and the right PPI network was created from samples without mutations in the LBS of TJP1. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for TJP1
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for TJP1
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of TJP1 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
IIIPeptide ligand (ARG,PRO,ARG,PRO,ASP,ASP,LEU,GLU,ILE)3cyyAK209 L242 I249 L256
IIIPeptide ligand (ARG,PRO,ARG,PRO,ASP,ASP,LEU,GLU,ILE)3cyyBK209 L242 I249 L256
IIIPeptide ligand (ARG,PRO,ARG,PRO,ASP,ASP,LEU,GLU,ILE)3cyyAN239
IIIPeptide ligand (ARG,PRO,ARG,PRO,ASP,ASP,LEU,GLU,ILE)3cyyBN239
IIIPeptide ligand (GLY,LYS,THR,SER,VAL,TRP,ILE)3shwAV450
IIIPeptide ligand (GLU,PHE,LYS,GLN,THR,SER,SER,PHE,LEU,VAL)3tszAV484 D514 L554 L558


Top
Conservation information for LBS of TJP1
Multiple alignments for Q07157 in multiple species
LBSAA sequence# speciesSpecies
A438VGLRLAGGNDV3Homo sapiens, Mus musculus, Canis lupus familiaris
A448VGIFVAGVLED3Homo sapiens, Mus musculus, Canis lupus familiaris
D514RIVESDVGDSF3Homo sapiens, Mus musculus, Canis lupus familiaris
D547VFRVVDTLYNG3Homo sapiens, Mus musculus, Canis lupus familiaris
E197SRKNEEYGLRL3Homo sapiens, Mus musculus, Canis lupus familiaris
E238NGTVTENMSLT3Homo sapiens, Mus musculus, Canis lupus familiaris
G199KNEEYGLRLAS3Homo sapiens, Mus musculus, Canis lupus familiaris
G439GLRLAGGNDVG3Homo sapiens, Mus musculus, Canis lupus familiaris
G552DTLYNGKLGSW3Homo sapiens, Mus musculus, Canis lupus familiaris
I249DAKTLIERSKG3Homo sapiens, Mus musculus, Canis lupus familiaris
K209SHIFVKEISQD3Homo sapiens, Mus musculus, Canis lupus familiaris
K246SLTDAKTLIER3Homo sapiens, Mus musculus, Canis lupus familiaris
K553TLYNGKLGSWL3Homo sapiens, Mus musculus, Canis lupus familiaris
L200NEEYGLRLASH3Homo sapiens, Mus musculus, Canis lupus familiaris
L202EYGLRLASHIF3Homo sapiens, Mus musculus, Canis lupus familiaris
L242TENMSLTDAKT3Homo sapiens, Mus musculus, Canis lupus familiaris
L256RSKGKLKMVVQ3Homo sapiens, Mus musculus, Canis lupus familiaris
L435GDSVGLRLAGG3Homo sapiens, Mus musculus, Canis lupus familiaris
L437SVGLRLAGGND3Homo sapiens, Mus musculus, Canis lupus familiaris
L451FVAGVLEDSPA3Homo sapiens, Mus musculus, Canis lupus familiaris
L487EAVLFLLDLPK3Homo sapiens, Mus musculus, Canis lupus familiaris
L488AVLFLLDLPKG3Homo sapiens, Mus musculus, Canis lupus familiaris
L549RVVDTLYNGKL3Homo sapiens, Mus musculus, Canis lupus familiaris
L554LYNGKLGSWLA3Homo sapiens, Mus musculus, Canis lupus familiaris
L558KLGSWLAIRIG3Homo sapiens, Mus musculus, Canis lupus familiaris
N239GTVTENMSLTD3Homo sapiens, Mus musculus, Canis lupus familiaris
N551VDTLYNGKLGS3Homo sapiens, Mus musculus, Canis lupus familiaris
R201EEYGLRLASHI3Homo sapiens, Mus musculus, Canis lupus familiaris
R436DSVGLRLAGGN3Homo sapiens, Mus musculus, Canis lupus familiaris
R480FTNIIREEAVL3Homo sapiens, Mus musculus, Canis lupus familiaris
R571HKEVERGIIPN3Homo sapiens, Mus musculus, Canis lupus familiaris
S432FRKGDSVGLRL3Homo sapiens, Mus musculus, Canis lupus familiaris
V236KINGTVTENMS3Homo sapiens, Mus musculus, Canis lupus familiaris
V433RKGDSVGLRLA3Homo sapiens, Mus musculus, Canis lupus familiaris
V450IFVAGVLEDSP3Homo sapiens, Mus musculus, Canis lupus familiaris
V484IREEAVLFLLD3Homo sapiens, Mus musculus, Canis lupus familiaris
V515IVESDVGDSFY3Homo sapiens, Mus musculus, Canis lupus familiaris
Y198RKNEEYGLRLA3Homo sapiens, Mus musculus, Canis lupus familiaris
Y550VVDTLYNGKLG3Homo sapiens, Mus musculus, Canis lupus familiaris


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas